RUNX3 and neoplasm: The frequency of promoter hypermethylation of the tumor suppressor gene loci included in the panel was FHIT 28%, FANCF 24%, Cyclin-D2 12%, BRCA2 4%, and RUNX3 56% of the 25 tumours (Table 1).